AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003
Patient Information Leaflet last updated on the eMC: 03/08/2009
PIL Avloclor Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 16/07/2008 and displayed until 03/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 17/06/2005 and displayed until 16/07/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 19/02/2004 and displayed until 17/06/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 26/09/2002 and displayed until 19/02/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   chloroquine phosphate


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk